Search jobs 10-Feb-2021 Thrombolytic Science Reinforces Its IP Portfolio with Patents in Europe, the Commonwealth of Independent States and Japan Thrombolytic Science Reinforces Its IP Portfolio with Patents in Europe, the Commonwealth of Independent States and Japan New Patents to Support Global Partnering of Novel Bio-inspired Clot-dissolving Therapy CAMBRIDGE, MA, February 10, 2021 / B3C newswire / --Thrombolytic Science, LLC (TSI) today announced the granting of three new patents during the last 12 months. The invention relates to methods and compositions for safe and effective thrombolysis for ischemic stroke and heart attacks. The two patents are part of a family of applications based on the international application No. PCT/US2015/058878. The European Patent Office granted Patent Number EP3215221 on February 26, 2020 and has been nationalized in 11 European countries. The Eurasian Patent Office granted Patent Number 035358 on June 1, 2020 and has been nationalized in 9 countries including Russia. The Japanese Patent Office granted Patent Number 6826040 on January 18, 2021.